Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of the American Medical Association (JAMA)

• Publication date

  2002-05-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/JAMA.287.20.2668PMID 12020302
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate.

  2001cited by this paper
• Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on plasma lipids and lipoproteins, coagulation factors, and carbohydrate metabolism.

  2001cited by this paper
• Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate.

  2001cited by this paper
• Is low-dose hormone replacement therapy for postmenopausal women efficacious and desirable?

  2001cited by this paper
• Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women.

  2001cited by this paper
• Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on endometrial bleeding.

  2001cited by this paper
• Personal perspective on low-dosage estrogen therapy for postmenopausal women.

  1999influential reference
• The effect of low-dose continuous estrogen and progesterone therapy with calcium and vitamin D on bone in elderly women. A randomized, controlled trial.

  1999cited by this paper
• Patient-Identified Needs for Hormone Replacement Therapy Counseling: A Qualitative Study

  1999influential reference
• HRT and Vit D in prevention of non-vertebral fractures in postmenopausal women; a 5 year randomized trial.

  1998cited by this paper
• Low-Dose Esterified Estrogen Therapy: Effects on Bone, Plasma Estradiol Concentrations, Endometrium, and Lipid Levels

  1997cited by this paper
• Prevention of postmenopausal bone loss with minimal uterine bleeding using low dose continuous estrogen/progestin therapy: a 2-year prospective study.

  1997cited by this paper
• Low-dose esterified estrogen therapy: effects on bone, plasma estradiol concentrations, endometrium, and lipid levels. Estratab/Osteoporosis Study Group.

  1997cited by this paper
• Medroxyprogesterone acetate enhances the spinal bone mineral density response to oestrogen in late post‐menopausal women

  1996cited by this paper
• Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin interventions (PEPI) trial. The Writing Group for the PEPI.

  1996cited by this paper
• The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART study). A randomized controlled trial.

  1996cited by this paper
• Medroxyprogesterone acetate enhances the spinal bone mineral density response to oestrogen in late postmenopausal women

  1996cited by this paper
• The worldwide problem of osteoporosis: insights afforded by epidemiology.

  1995cited by this paper
• Effects of 2 years of hormone replacement upon bone mass, serum lipids and lipoproteins.

  1994cited by this paper
• Continuous low‐dose oestrogen and progestogen hormone replacement therapy: a randomised trial

  1993cited by this paper
• Treatment of Postmenopausal Osteoporosis with Transdermal Estrogen

  1992cited by this paper
• A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women

  1991cited by this paper
• Effect of progestin therapy on cortical and trabecular bone: comparison with estrogen.

  1991cited by this paper
• The Minimum Effective Dose of Estrogen for Prevention of Postmenopausal Bone Loss

  1984cited by this paper
• Quantitative Computed Tomography of Vertebral Spongiosa: A Sensitive Method for Detecting Early Bone Loss After Oophorectomy

  1982cited by this paper
• Prevention of spinal osteoporosis in oophorectomised women.

  1980cited by this paper

• Impact of estroprogestin therapies on bone health from adolescence to postmenopause.

  2026cites this paper
• Tissue-specific mechanism of estrogen in osteoporosis and vascular calcification.

  2025cites this paper
• Bone Health for Gynaecologists

  2025cites this paper
• Can menopausal hormone therapy be considered in postmenopausal women who are older than 60 years?

  2025influential citation
• The 2025 Menopausal Hormone Therapy Guidelines - Korean Society of Menopause

  2025cites this paper
• Global, regional, and National burden of falls among midlife women from 1990 to 2021 and projections to 2050: A systematic analysis for the global burden of disease study 2021

  2025cites this paper
• Insights and implications of sexual dimorphism in osteoporosis

  2024cites this paper
• A protocol to assess risk of fractures associated with use of menopausal hormone therapy: nested case-control study using CPRD

  2024cites this paper
• Bone health in childhood cancer survivors, is there really a problem? Pitfalls of assessment, calculating risk, and suggested surveillance and management for osteonecrosis and low and very low bone mineral density

  2024cites this paper
• Modulation of Bone Mineral Density and Its Response to Menopausal Hormone Therapy according to the Apolipoprotein E Genotype in Postmenopausal Korean Women

  2024cites this paper
• Genetic Prediction of Osteoporosis by Anti-Müllerian Hormone Levels and Reproductive Factors in Women: A Mendelian Randomization Study

  2024cites this paper
• Hormone therapy for sexual function in perimenopausal and postmenopausal women.

  2023cites this paper
• Reappraising 21 years of the WHI study: Putting the findings in context for clinical practice.

  2023cites this paper
• Knochengesundheit in der Postmenopause

  2023cites this paper
• Postmenopausal Osteoporosis: Menopause Hormone Therapy and Selective Estrogen Receptor Modulators

  2023influential citation
• Relationship between menopausal hormone therapy and incidence of fractures in postmenopausal women

  2023cites this paper
• The role of menopausal hormone therapy in the prevention and treatment of low bone density in perimenopausal and postmenopausal women

  2023influential citation
• The 2022 hormone therapy position statement of The North American Menopause Society

  2022cites this paper
• Management of menopause: a view towards prevention.

  2022cites this paper
• Coronary artery calcium and bone mineral density by serial CTA: Does menopausal hormone therapy modify the association?

  2022cites this paper
• Management of postmenopausal women: Collège National des Gynécologues et Obstétriciens Français (CNGOF) and Groupe d'Etude sur la Ménopause et le Vieillissement (GEMVi) Clinical Practice Guidelines.

  2022cites this paper
• Knochengesundheit in der Postmenopause

  2022cites this paper
• Terapia ormonale sostitutiva e osteoporosi postmenopausale

  2022influential citation
• Efficacy of minodronic acid for the prevention of osteoporosis in premenopausal women with gynaecologic disease who undergo bilateral oophorectomy: a single-centre, non-randomised controlled, experimental study

  2022cites this paper
• Management of osteoporosis in postmenopausal women: the 2021 position statement of The North American Menopause Society

  2021cites this paper
• Menopausal hormone therapy for the management of osteoporosis.

  2021cites this paper
• Fracture recurrence in hip fracture with menopausal hormone therapy versus risedronate: a clinical trial

  2021cites this paper
• [Menopause, menopause hormone therapy and osteoporosis. CNGOF and GEMVi clinical practice guidelines].

  2021cites this paper
• Hormone therapy for postmenopausal osteoporosis management

  2021cites this paper
• Hormone Therapy in Menopause: Concepts, Controversies, and Approach to Treatment

  2021cites this paper
• Der Einfluss der Gestagene auf die Knochengesundheit

  2020cites this paper
• Dual targeting of SREBP2 and ERRα by carnosic acid suppresses RANKL-mediated osteoclastogenesis and prevents ovariectomy-induced bone loss

  2020cites this paper
• Estrogen and bones after menopause: a reappraisal of data and future perspectives

  2020cites this paper
• The 2020 Menopausal Hormone Therapy Guidelines

  2020cites this paper
• THE KOREAN SOCIETY OF MENOPAUSE PAGES

  2020cites this paper
• Matriz de recomendações para farmacoterapia da osteoporose e da osteoartrite: recurso para subsidiar a adaptação de guias de prática clínica

  2019cites this paper
• Long-Term Drug Therapy and Drug Holidays for Osteoporosis Fracture Prevention: A Systematic Review

  2019cites this paper
• Ovarian Hormones and Bone

  2019cites this paper
• Menopause and Aging

  2019cites this paper
• Risks and benefits of menopausal hormone therapy

  2019cites this paper
• Effect of Menopausal Hormone Therapy on Bone Mineral Density in Chinese Women: A 2-Year, Prospective, Open-Label, Randomized-Controlled Trial

  2019influential citation
• Der Einfluss der Gestagene auf die Knochengesundheit

  2019cites this paper
• Os et cartilage

  2019cites this paper
• Effects of ultra-low dose hormone therapy on biochemical bone turnover markers in postmenopausal women: A randomized, placebo-controlled, double-blind trial

  2019cites this paper
• PREVENTION/IMPACT OF LIFESTYLE 25 IMPACT OF LIFESTYLE VERSUS HRT ON DIFFERENT CANCERS AFTER MENOPAUSE

  2018cites this paper
• Progesterone for treatment of symptomatic menopausal women

  2018cites this paper
• Healthy Bones After Menopause: What Has to Be Done?

  2018cites this paper
• Commission de la transparence

  2018cites this paper
• Bone protection for early menopausal women in China: standard or half-dose estrogen with progestin? A one-year prospective randomized trail

  2018cites this paper
• Advances in osteoporosis from 1970 to 2018.

  2018influential citation
• Estrogen therapy for osteoporosis in the modern era

  2018cites this paper
• Hormone therapy for the treatment of postmenopausal osteoporosis: will it soon become a lost art in medicine?

  2018cites this paper
• Consensus statement on the use of HRT in postmenopausal women in the management of osteoporosis by SIE, SIOMMMS and SIGO

  2018cites this paper
• Effects of Combination Therapy of Alendronate and Hormonal Therapy on Bone Mineral Density in Postmenopausal Korean Women: Multicenter, Randomized Controlled Clinical Trial

  2017cites this paper
• Five Decades of Hormone Therapy Research: The Long, the Short, and the Inconclusive

  2017cites this paper
• Treatment with Standard and Low Dose of Conjugated Equine Estrogen Differentially Modulates Estrogen Receptor Expression and Response to Angiotensin II in Mesenteric Venular Bed of Surgically Postmenopausal Hypertensive Rats

  2017cites this paper
• Estrogen-progestin therapy causes a greater increase in spinal bone mineral density than estrogen therapy - a systematic review and meta-analysis of controlled trials with direct randomization

  2017cites this paper
• The impact of estrogen alone hormone therapy on breast cancer risk and health outcomes: reassurance for the treatment of climacteric symptoms in black women?

  2017cites this paper
• Postmenopausal Estrogen for Treatment of Hot Flashes

  2017cites this paper
• Cancer Risk-Reducing Opportunities in Gynecologic Surgery.

  2017cites this paper
• Estrogen alone and health outcomes in black women by African ancestry: a secondary analyses of a randomized controlled trial

  2017cites this paper
• Osteoporosis for the Female Patient

  2017cites this paper
• Obowiązujące wskazania do prewencji i leczenia osteoporozy pomenopauzalnej — choroby miliona złamań

  2016influential citation
• Hormone Replacement Therapy Versus the Combined Oral Contraceptive Pill in Premature Ovarian Failure: A Randomized Controlled Trial of the Effects on Bone Mineral Density.

  2016cites this paper
• Comparative efficacy and safety of estradiol transdermal preparations for the treatment of vasomotor symptoms in postmenopausal women: an indirect comparison meta-analysis

  2016cites this paper
• Evaluation and Treatment of Osteoporosis.

  2016cites this paper
• Postmenopausal syndrome

  2015cites this paper
• Terapia hormonal en la post menopausia a la luz de los resultados de grandes estudios

  2015cites this paper
• Hormone therapy for preventing cardiovascular disease in post-menopausal women.

  2015cites this paper
• Perspective Primary osteoporosis in postmenopausal women

  2015cites this paper
• Novel therapies for osteoporosis.

  2015cites this paper
• Hormonal Add-Back Therapy for Females Treated With Gonadotropin-Releasing Hormone Agonist for Endometriosis: A Randomized Controlled Trial

  2015cites this paper
• Isoflavone supplementation reduced serum sex hormone- binding globulin concentration in postmenopausal women

  2015cites this paper
• Estrogens, Progestins, SERMs, and Osteoporosis

  2015cites this paper
• Primary osteoporosis in postmenopausal women

  2015influential citation
• Menopause and HRT: Doubts and Certainties

  2015cites this paper
• Diagnosis and Management of Osteoporosis.

  2015cites this paper
• The Role of Estrogen Receptor in Bone Cells

  2015cites this paper
• Osteoporosis in menopause.

  2014cites this paper
• Osteoporosis: The Need for Prevention and Treatment

  2014cites this paper
• What should we be advising women about hormone replacement therapy?

  2014cites this paper
• Management of postmenopausal osteoporosis and the prevention of fractures.

  2014cites this paper
• Postmenopause and Ageing: The Concept of Personalized Therapy

  2014cites this paper
• Chapter 15 – Menopause and Aging

  2014cites this paper
• Negative spinal bone mineral density changes and subclinical ovulatory disturbances--prospective data in healthy premenopausal women with regular menstrual cycles.

  2014cites this paper
• Conjugated estrogens for the treatment of menopausal symptoms: a review of safety data

  2014cites this paper
• Current and evolving approaches to individualizing estrogen receptor-based therapy for menopausal women.

  2014influential citation
• Hormone replacement therapy and the prevention of postmenopausal osteoporosis

  2014influential citation
• Ostéoporose pendant la ménopause.

  2014cites this paper
• Effect of Transdermal Estrogen Therapy on Bone Mineral Density in Postmenopausal Korean Women

  2014cites this paper
• Prevention and treatment of postmenopausal osteoporosis.

  2014cites this paper
• Estrogen treatment does not reduce fractures?

  2014cites this paper
• Effects of bazedoxifene/conjugated estrogens on the endometrium and bone: a randomized trial.

  2014cites this paper
• Women’s Health Initiative clinical trials: interaction of calcium and vitamin D with hormone therapy

  2014influential citation
• Profile of bazedoxifene/conjugated estrogens for the treatment of estrogen deficiency symptoms and osteoporosis in women at risk of fracture

  2013cites this paper
• Influence of estrogen therapy on calcium, phosphorus, and other regulatory hormones in postmenopausal women: the MESA study.

  2013cites this paper
• Tissue selective estrogen complex combinations with bazedoxifene/conjugated estrogens as a model

  2013cites this paper
• Biochemical Markers of Bone Turnover in Osteoporosis

  2013cites this paper
• Menopause and Care of the Mature Woman

  2013cites this paper
• Effects of estrogen with micronized progesterone on cortical and trabecular bone mass and microstructure in recently postmenopausal women.

  2013cites this paper